Multiple fatty acids and enzymes involved in fatty acid metabolism, such as fatty acid-binding protein 4 (FABP4), CD36 and stearoyl-CoA desaturase 1 (SCD1), significantly enhance ovarian cancer proliferation, survival, drug resistance and metastasis, and even contribute to stemness maintenance (14, 18–21). Here, FABP4 is linked to ovarian cancer.